Biotechnology

Working in concert with multiple practice groups, Haynes Boone provides full life cycle support for Life Sciences companies of all sizes. Whether a small start-up or a large multi-national company, we tailor our approach to solve your most complex challenges.

Haynes Boone’s Biotechnology Intellectual Property team provides legal insight on intellectual property strategy, patent prosecution and transactional IP due diligence. Our practitioners routinely handle domestic and foreign prosecution for patent portfolios of all sizes, providing sophisticated counseling and portfolio management, as well as representation in post-grant proceedings at the U.S. Patent and Trademark Office (USPTO), litigation in federal courts and cases before the U.S. International Trade Commission (ITC).

We have devised IP strategies that encompass not only patents, but also data rights and the strategic use of trade secrets to provide overlapping end-to-end protection for proprietary products and services and partnering agreements to leverage or monetize such technology and IP rights.

We understand the Biotechnology industry inside and out – from where it’s been, to where it is, to where it’s going next. As a result, clients turn to Haynes Boone’s Biotechnology Intellectual Property team for strategic counseling in many diverse Biotechnology areas, including:

• Large Molecule Therapeutics
• Small Molecule Therapeutics
• Cellular Therapeutics
• Monoclonal Antibodies, Antibody Drug Conjugates (ADCs), Bispecific T-cell Engagers (TCEs) and CAR-T Cells
• Genomic Analysis and Gene Editing
• Immunology
• Computational Biology
• Molecular Diagnostics
• Synthetic Oligosaccharides
• Alternative Foods/Meat Substitutes
• Bioprocess Manufacturing
• Tumor Profiling Assays and Interpretive Software
• AI/Machine Learning as applied to the Life Sciences Sector